Long-Term Weight Maintenance Perhaps most critically, muscle mass predicts weight maintenance success
And unlike tirzepatide or semaglutide, phentermine is not a GLP-1 agonist , so it does not provide the metabolic and glycemic benefits that incretin-based therapies deliver
When combined with levocarnitine, the theoretical benefit is an additive or even synergistic effect on hepatic fat reduction: tirzepatide reduces the caloric load and improves systemic insulin sensitivity, while levocarnitine enhances the liver ability to oxidize existing fat stores and reduce inflammation
Some early research also suggests it might help protect nerves, which could matter for certain types of chronic pain
(PDF) Robble, M.A*, Schroder, H.S.*, Kangas, B.D., Nickels, S., Breiger, M., Iturra-Mena, A., Perlo, S., Cardenas, E., Der-Avakian, A., Barnes, S.A., Leutgeb, S., Risbrough, V.B., Vitaliano, G., Bergman, J., Carlezon, W.A., Jr
Pre-existing diabetic neuropathy or underlying gastric motility disorders may delay or limit complete symptom resolution after medication cessation